Deutsche Bank Ag\ Ironwood Pharmaceuticals Inc Transaction History
Deutsche Bank Ag\
- $248 Billion
- Q4 2024
A detailed history of Deutsche Bank Ag\ transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,567,535 shares of IRWD stock, worth $2.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,567,535
Previous 1,063,199
47.44%
Holding current value
$2.34 Million
Previous $4.37 Million
58.94%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding IRWD
# of Institutions
244Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$34.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$29.1 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$24.4 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$17.5 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$14.1 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $228M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...